Locoid 0.1% cream

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktif bileşen:

Hydrocortisone butyrate

Mevcut itibaren:

Neon Healthcare Ltd

ATC kodu:

D07AB02

INN (International Adı):

Hydrocortisone butyrate

Doz:

1mg/1gram

Farmasötik formu:

Cutaneous cream

Uygulama yolu:

Cutaneous

Sınıf:

No Controlled Drug Status

Reçete türü:

Valid as a prescribable product

Ürün özeti:

BNF: 13040000; GTIN: 5013346026097 5013346026110

Bilgilendirme broşürü

IAT001 (LFT293) Page 1+2, 145x270 mm
053120
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leafl et. You may need to read it again.
•
If you have any further questions, ask your doctor, pharmacist or
nurse.
•
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if their
signs of illness are the same as yours.
•
If you get any side eff ects, talk to your doctor, pharmacist or
nurse. This includes any possible side eff ects
not listed in this leafl et. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Locoid Cream is and what it is used for
2.
What you need to know before you use Locoid Cream
3.
How to use Locoid Cream
4.
Possible side eff ects
5.
How to store Locoid Cream
6.
Contents of the pack and other information
1. WHAT LOCOID CREAM IS AND WHAT IT IS USED FOR
Locoid Cream contains the active substance hydrocortisone butyrate.
This is a corticosteroid which when
made up as a cream is for use on the skin. This is known as topical
application. Topical corticosteroids are
ranked as mildly potent, moderately potent, potent and very potent;
Locoid Cream is classed as potent.
Topical corticosteroids are able to reduce the infl ammation caused by
a variety of skin conditions, and so
allow it to get better. They can also aff ect the cause of the
condition, which can lead to its healing.
Locoid Cream is indicated in adults, children and infants. It is used
to treat a variety of skin conditions that
respond to topical corticosteroids. Among these are eczema and
dermatitis (itching) of all types including
atopic (childhood) eczema, photodermatitis (itching caused by exposure
to light) and dermatitis caused by
skin irritants and allergies.
It can also be used in the treatment of psoriasis, a condition
resulting in thickening of areas of the skin. It is
important that you follow your doctor’s instructions particularly in
psoriasis, and use it only on small areas on
the scalp, hands o

Ürün özellikleri

OBJECT 1
LOCOID CREAM
Summary of Product Characteristics Updated 15-Sep-2016 | Leo
Laboratories Limited
1. Name of the medicinal product
Locoid cream
2. Qualitative and quantitative composition
Locoid Cream contains 0.1% w/w hydrocortisone butyrate.
Excipient(s) with known effect:
Cetostearyl alcohol (7.2% w/w)
Butyl parahydroxybenzoate (0.05% w/w)
Propyl parahydroxybenzoate (0.1% w/w)
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Cream.
The product is a white to practically white cream.
4. Clinical particulars
4.1 Therapeutic indications
Locoid Cream is indicated in adults, children and infants. The product
is recommended for clinical use in
the treatment of conditions responsive to topical corticosteroids e.g.
eczema, dermatitis and psoriasis.
Topical corticosteroids are not generally indicated in psoriasis but
may be acceptable in psoriasis
excluding widespread plaque psoriasis provided warnings are given, see
section 4.4 Special warnings and
precautions for use.
4.2 Posology and method of administration
Posology
_Adults and older people_
The same dose is used for adults and older people, as clinical
evidence would indicate that no special
dosage regimen is necessary in older people.
_Paediatric population_
Long term treatment should be avoided where possible.
_Infants_
Therapy should be limited if possible to a maximum of seven days.
Method of administration
For cutaneous use.
Dosage: To be applied evenly and sparingly no more than twice daily.
Application may be made under occlusion in the more resistant lesions
such as thickened psoriatic
plaques on elbows and knees.
4.3 Contraindications
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.
This preparation is contraindicated in the presence of untreated viral
or fungal infections, tubercular or
syphilitic lesions, peri-oral dermatitis, acne vulgaris and rosacea
and in bacterial infections unless used in
connection with appropriate chemotherapy.
4.4 Special warnings and precautions for use
Ap